Shkreli previously spent nearly seven years in prison on charges of defrauding investors. The current proceedings, launched by the FTC and state attorneys general, seek to hold the convicted fraudster in contempt for his continued financial activity and involvement within the pharmaceutical industry.
Tuesday, October 20, 2026
Story
FTC and 7 States Sue Martin Shkreli Over Lifetime Pharma Ban
US Politics7 days ago
A contempt claim was filed on Tuesday alleging that the former drug executive repeatedly ignored a court order that prohibited him from working in the medical sector. The Federal Trade Commission and seven states claim that Martin Shkreli held more than 60 pharmaceutical stocks despite a 2022 lifelong ban on his industry participation, accusing the figure known as “Pharma Bro” of flagrantly violating the court's decision.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.